Literature DB >> 31425672

An innovative and user-friendly scoring system for standardised quantitative interpretation of the urine-based point-of-care strip test (POC-CCA) for the diagnosis of intestinal schistosomiasis: a proof-of-concept study.

Miriam Casacuberta-Partal1, Pytsje T Hoekstra2, Dieuwke Kornelis3, Lisette van Lieshout4, Govert J van Dam5.   

Abstract

The point-of-care strip assay for the detection of the schistosome Circulating Cathodic Antigen (POC-CCA) in urine has shown to be a user-friendly and sensitive alternative to stool microscopy for the diagnosis of Schistosoma mansoni infections. However, visual scoring of the test is by definition observer dependent and leads to discussion about the qualitative interpretation, in particular in low intensity infections when test lines tend to be weak. In order to standardise visual scoring, an innovative approach for semi-quantitative interpretation of the POC-CCA cassettes, called G-scores, was developed and evaluated. Urines (n = 110) from a S. mansoni endemic area were used to evaluate this new approach. Test lines of the POC-CCA were visually compared against the G-scores, i.e. a series of artificial cassettes containing inkjet-printed strips of different intensities in order to grade the POC-CCA test line on a scale of 1 to 10. A significant positive correlation (Spearman 0.660, p < 0.001) was observed between G-scores and eggs per gram of faeces. This proof-of-concept study demonstrates the usefulness of the G-scores for standardising the visual scoring of the POC-CCA urine strip assay. Several research groups have already indicated an interest in the G-scores for their field work. Further distribution of the cassettes, in particular when provided in combination with reference standards, will assist the wider schistosomiasis community in dealing with issues like batch-to-batch differences and interpretation of trace readings.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  G-scores; POC-CCA: Circulating Cathodic Antigen; Semi-quantification; Visual score

Mesh:

Substances:

Year:  2019        PMID: 31425672     DOI: 10.1016/j.actatropica.2019.105150

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  13 in total

1.  Translating From Egg- to Antigen-Based Indicators for Schistosoma mansoni Elimination Targets: A Bayesian Latent Class Analysis Study.

Authors:  Jessica Clark; Arinaitwe Moses; Andrina Nankasi; Christina L Faust; Moses Adriko; Diana Ajambo; Fred Besigye; Arron Atuhaire; Aidah Wamboko; Candia Rowel; Lauren V Carruthers; Rachel Francoeur; Edridah M Tukahebwa; Poppy H L Lamberton; Joaquin M Prada
Journal:  Front Trop Dis       Date:  2022-02-18

2.  Detecting Schistosoma mansoni infections among pre-school-aged children in southern Ghana: a diagnostic comparison of urine-CCA, real-time PCR and Kato-Katz assays.

Authors:  Samuel Armoo; Lucas J Cunningham; Suzy J Campbell; Frank T Aboagye; Freda K Boampong; Buhari A Hamidu; Mike Y Osei-Atweneboana; J Russell Stothard; Emily R Adams
Journal:  BMC Infect Dis       Date:  2020-04-22       Impact factor: 3.090

3.  Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections.

Authors:  Daniel G Colley; Charles H King; Nupur Kittur; Reda M R Ramzy; William Evan Secor; Merlene Fredericks-James; Giuseppina Ortu; Michelle N Clements; Eugene Ruberanziza; Irenee Umulisa; Udo Wittmann; Carl H Campbell
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

4.  A cluster randomized controlled trial for assessing POC-CCA test based praziquantel treatment for schistosomiasis control in pregnant women and their young children: study protocol of the freeBILy clinical trial in Madagascar.

Authors:  Daniela Fusco; Raphäel Rakotozandrindrainy; Rivo Andry Rakotoarivelo; Mala Rakoto Andrianarivelo; Njary Rakotozandrindrainy; Tahinamandranto Rasamoelina; Dewi Ismajani Puradiredja; Philipp Klein; Karl Stahlberg; Marie Dechenaud; Eva Lorenz; Anna Jaeger; Andrea Kreidenweiss; Pytsje T Hoekstra; Akim Ayola Adegnika; Elisa Sicuri; Paul L A M Corstjens; Govert J van Dam; Jürgen May; Norbert Georg Schwarz
Journal:  Trials       Date:  2021-11-20       Impact factor: 2.279

5.  Candidate gene family-based and case-control studies of susceptibility to high Schistosoma mansoni worm burden in African children: a protocol.

Authors:  Oscar A Nyangiri; Sokouri A Edwige; Mathurin Koffi; Estelle Mewamba; Gustave Simo; Joyce Namulondo; Julius Mulindwa; Jacent Nassuuna; Alison Elliott; Kévin Karume; Dieudonne Mumba; P L A M Corstjens; M Casacuberta-Partal; G J van Dam; Bruno Bucheton; Harry Noyes; Enock Matovu
Journal:  AAS Open Res       Date:  2021-12-15

6.  Reliability of point-of-care circulating cathodic antigen assay for diagnosing schistosomiasis mansoni in urine samples from an endemic area of Brazil after one year of storage at -20 degrees Celsius.

Authors:  Tereza Cristina Favre; Lilian Christina Nóbrega Holsback Beck; Fernando Schemelzer Moraes Bezerra; Carlos Graeff-Teixeira; Paulo Marcos Zech Coelho; Martin Johannes Enk; Naftale Katz; Ricardo Riccio Oliveira; Mitermayer Galvão Dos Reis; Otávio Sarmento Pieri
Journal:  Rev Soc Bras Med Trop       Date:  2022-02-25       Impact factor: 1.581

7.  Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial.

Authors:  Clémentine Roucher; Isabel Brosius; Katja Polman; Emmanuel Bottieau; Moustapha Mbow; Babacar Thiendella Faye; Annelies De Hondt; Bart Smekens; Diana Arango; Christophe Burm; Achilleas Tsoumanis; Linda Paredis; Yven van Herrewege; Idzi Potters; Badara Cisse; Souleymane Mboup
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692

8.  Prevalence of intestinal schistosomiasis in pre-school aged children: a pilot survey in Marolambo District, Madagascar.

Authors:  Caitlin Sheehy; Heather Lawson; Emmanuel H Andriamasy; Hannah J Russell; Alice Reid; Gina U Raderalazasoa; Graham Dodge; Robbie Kornitschky; James M StJ Penney; Tahiry N Ranaivoson; Antsa Andrianiaina; Jenny S Emmanoela; Amaya L Bustinduy; J Russell Stothard; Louis Andrianjaka; Stephen A Spencer
Journal:  Infect Dis Poverty       Date:  2021-06-25       Impact factor: 4.520

9.  Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).

Authors:  Pytsje T Hoekstra; Miriam Casacuberta-Partal; Lisette van Lieshout; Paul L A M Corstjens; Roula Tsonaka; Rufin K Assaré; Kigbafori D Silué; Aboulaye Meité; Eliézer K N'Goran; Yves K N'Gbesso; Abena S Amoah; Meta Roestenberg; Stefanie Knopp; Jürg Utzinger; Jean T Coulibaly; Govert J van Dam
Journal:  PLoS Negl Trop Dis       Date:  2020-03-20

10.  Cross-reaction of POC-CCA urine test for detection of Schistosoma mekongi in Lao PDR: a cross-sectional study.

Authors:  Anousin Homsana; Peter Odermatt; Phonesavanh Southisavath; Aya Yajima; Somphou Sayasone
Journal:  Infect Dis Poverty       Date:  2020-08-12       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.